Turk J Gastroenterol
-
Turk J Gastroenterol · Sep 2006
Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis.
Serum pepsinogen levels are considered as a non-endoscopic blood test in the diagnosis of atrophic gastritis. The objective of the present study was to investigate whether there is any difference between pepsinogen levels in Helicobacter pylori-positive and -negative patients with atrophic gastritis, and to analyze the relationship between histopathology and pepsinogen levels after treatment in H. pylori-positive patients with atrophic gastritis. ⋯ In atrophic gastritis, the levels of serum pepsinogen and pepsinogen I/II ratio show a difference in H. pylori-negative versus -positive cases. Additionally, the usage of pepsinogen II as a serum marker in predicting the eradication of H. pylori with atrophic gastritis could be more reliable than pepsinogen I or the I/II ratio.
-
Turk J Gastroenterol · Sep 2006
Characterization of focal liver lesions: use of mangafodipir trisodium (MnDPDP)-enhanced MR images.
We evaluated the characterization and detection of liver lesions using mangafodipir trisodium. ⋯ Mangafodipir trisodium-enhanced MRI permits reliable distinction between hepatocellular and non-hepatocellular tumors. Mangafodipir trisodium-enhanced MRI can show more functional and morphologic features of hepatocellular lesions. Some non-hepatocellular lesions which went undetected on unenhanced MRI were visualized after contrast enhancement of the liver. The rim-like enhancement pattern is not specific for metastases. Mangafodipir trisodium-enhanced MRI is safe and well tolerated and may aid in noninvasive diagnosis of liver lesions.
-
The aim of this study was to evaluate the nutritional status of children at the moment of their hospitalization and to investigate whether there is a relation between the diagnosis and nutritional status. ⋯ Malnutrition among hospitalized children and especially those with chronic diseases is worth attention. Evaluation of the nutritional status and nutritional support are elements of the diagnostic and treatment process. In particular, closer observation and nutritional support are required in the cases of patients diagnosed with chronic kidney insufficiency, immune insufficiency, neurological diseases, and cystic fibrosis.
-
Turk J Gastroenterol · Sep 2005
Randomized Controlled TrialManagement of fatty liver disease with vitamin E and C compared to ursodeoxycholic acid treatment.
Despite a proposed role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis, antioxidant approaches have not been investigated sufficiently in the therapy of nonalcoholic steatohepatitis. Our aim was to determine whether vitamin E plus C therapy is effective in normalization of liver enzymes compared to ursodeoxycholic acid treatment in patients with fatty liver disease. ⋯ Vitamin E plus C combination treatment is a safe, inexpensive and effective treatment option in patients with fatty liver disease, with results comparable to those obtained with ursodeoxycholic acid. Since more effective new therapeutic options are lacking, patients with fatty liver disease should be encouraged to take vitamin E and C supplements, which are safe and affordable.
-
Turk J Gastroenterol · Sep 2005
Ultrasound-guided percutaneous cholecystostomy for acute cholecystitis in critically ill patients: one center's experience.
The standard treatment for acute cholecystitis is cholecystectomy; however, cholecystectomy is not an option in some patients who are too high-risk for emergency surgery. Ultrasound-guided percutaneous cholecystostomy is an alternative for such patients. This study presents one center's five-year clinical experience with ultrasound-guided percutaneous cholecystostomy for treatment of acute cholecystitis. ⋯ Ultrasound-guided percutaneous cholecystostomy is a relatively safe and easy method for treating acute cholecystitis in critically ill patients. The risk of complications is low and the likelihood of success is high.